KRSA peer analysis
Korsana Biosciences (KRSA) against its competitors: price, today's move, 1-year return and market value side by side.
KRSA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADXN Addex Therapeutics | $2.79 | -3.79% | – | $3.44M |
| AIM AIM ImmunoTech | $0.14 | -12.10% | -91.22% | $5.51M |
| KTTA Pasithea Therapeutics | $0.57 | 5.81% | -21.52% | $19.17M |
| PLRZ Polyrizon | $11.05 | 0.05% | 112.15% | $12.38M |
| QNRX Quoin Pharmaceuticals | $3.73 | -4.48% | -54.18% | $7.49M |
| RADX Radiopharm | $0.89 | -7.70% | -81.83% | $1.14M |
| TCRT Alaunos Therapeutics | $1.71 | 0.29% | -32.21% | $4.36M |
| XTLB XTL Biopharmaceuticals | $1.71 | 11.43% | -59.40% | $1.61M |
| KRSA Korsana Biosciences | $31.11 | -0.19% | – | $145.64M |
- KRSA's peers: ADXN (Addex Therapeutics), AIM (AIM ImmunoTech), KTTA (Pasithea Therapeutics), PLRZ (Polyrizon), QNRX (Quoin Pharmaceuticals), RADX (Radiopharm), TCRT (Alaunos Therapeutics), XTLB (XTL Biopharmaceuticals).
Updated 2026-11-11 15:53 UTC